Changes in content of triterpenoids and polysaccharides in Ganoderma lingzhi at different growth stages
暂无分享,去创建一个
K. Ohnuki | Y. Inoue | T. Nakagawa | Qinchang Zhu | Yhiya Amen | Shuhei Kaneko | H. Kawashima | H. Suhara | Sonam Tamrakar | Y. Mori | K. Shimizu | Kotaro Okuzono | Yoshiyuki Inoue | Kuniyoshi Shimizu | Hiroto Suhara
[1] S. Morimoto,et al. Tubulin polymerization-stimulating activity of Ganoderma triterpenoids , 2017, Journal of Natural Medicines.
[2] Peng Xia,et al. Polysaccharides from Ganoderma lucidum Promote Cognitive Function and Neural Progenitor Proliferation in Mouse Model of Alzheimer's Disease , 2017, Stem cell reports.
[3] K. Shimizu,et al. New cytotoxic lanostanoid triterpenes from Ganoderma lingzhi , 2016 .
[4] Jun-Wei Xu,et al. Enhancement of ganoderic acid production by constitutively expressing Vitreoscilla hemoglobin gene in Ganoderma lucidum. , 2016, Journal of biotechnology.
[5] K. Shimizu,et al. Lucidumol C, a new cytotoxic lanostanoid triterpene from Ganoderma lingzhi against human cancer cells , 2016, Journal of Natural Medicines.
[6] K. Ohnuki,et al. Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design , 2015, Scientific Reports.
[7] J. Goldfarb,et al. Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI™ suppresses TNF-α production by mouse macrophages and peripheral blood mononuclear cells from asthma patients. , 2015, International immunopharmacology.
[8] Jun-Wei Xu,et al. Ganoderic Acid Accumulation and Biosynthetic Gene Expression during Fruiting Body Development in Ganoderma lucidum , 2015 .
[9] K. Shimizu,et al. Structure–activity relationship and inhibition pattern of reishi-derived (Ganoderma lingzhi) triterpenoids against angiotensin-converting enzyme , 2015 .
[10] Sabulal Baby,et al. Secondary metabolites from Ganoderma. , 2015, Phytochemistry.
[11] Lei Wei,et al. Extraction optimization of total triterpenoids from Jatropha curcas leaves using response surface methodology and evaluations of their antimicrobial and antioxidant capacities , 2015 .
[12] Xin-feng Zhang,et al. [Study on variation of main ingredients from spores and fruiting bodies of Ganoderma lucidum]. , 2014, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[13] R. Kondo,et al. Structure-activity relationships of lanostane-type triterpenoids from Ganoderma lingzhi as α-glucosidase inhibitors. , 2013, Bioorganic & medicinal chemistry letters.
[14] P. Zhou,et al. Antidiabetic, Antihyperlipidemic and Antioxidant Activities of a Novel Proteoglycan from Ganoderma Lucidum Fruiting Bodies on db/db Mice and the Possible Mechanism , 2013, PloS one.
[15] R. Kondo,et al. Quantitative determination of the representative triterpenoids in the extracts of Ganoderma lucidum with different growth stages using high-performance liquid chromatography for evaluation of their 5α-reductase inhibitory properties , 2012 .
[16] K. Skalicka‐Woźniak,et al. Evaluation of polysaccharides content in fruit bodies and their antimicrobial activity of four Ganoderma lucidum (W Curt.: Fr.) P. Karst. strains cultivated on different wood type substrates , 2012 .
[17] R. Kondo,et al. Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors. , 2011, Bioorganic & medicinal chemistry letters.
[18] Qing-xi Yue,et al. Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[19] T. Hsia,et al. Gandoderma lucidum extract promotes immune responses in normal BALB/c mice In vivo. , 2009, In vivo.
[20] Zhi-bin Lin. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. , 2005, Journal of pharmacological sciences.
[21] Zhi-bin Lin,et al. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. , 2004, Acta pharmacologica Sinica.
[22] S. Gordon,et al. Dectin-1 Mediates the Biological Effects of β-Glucans , 2003, The Journal of experimental medicine.
[23] M. Recio,et al. On the anti-inflammatory and anti-phospholipase A(2) activity of extracts from lanostane-rich species. , 2000, Journal of ethnopharmacology.
[24] E. Pichersky,et al. Genetics and biochemistry of secondary metabolites in plants: an evolutionary perspective. , 2000, Trends in plant science.
[25] M. Berovič,et al. Isolation and quantification of triterpenoid acids from Ganoderma applanatum of Istrian origin. , 2000 .
[26] S. Eo,et al. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. , 1999, Journal of ethnopharmacology.
[27] Ha Won Kim,et al. Biomedicinal Triterpenoids of Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae) , 1999 .
[28] S. Eo,et al. Antimicrobial activity ofGanoderma lucidum extract alone and in combination with some antibiotics , 1994, Archives of pharmacal research.
[29] T. Furuya,et al. Comparative study on the strain-specific triterpenoid components of Ganoderma lucidum☆ , 1993 .
[30] H. Fujimoto,et al. New Toxic Metabolites from a Mushroom, Hebeloma vinosophyllum. III. Isolation and Structures of Three New Glycosides, Hebevinosides XII, XIII and XIV, and Productivity of the Hebevinosides at Three Growth Stages of the Mushroom , 1991 .
[31] T. Furuya,et al. Changes of the triterpenoid patterns during formation of the fruit body in Ganoderma lucidum , 1990 .
[32] 道徳 久保,et al. 霊芝(Ganoderma lucidum, 子実体)の研究(第4報)播種性血管内凝固に対する作用 , 1983 .
[33] M. Nogami,et al. [Ganoderma lucidum. (4) Effects on disseminated intravascular coagulation]. , 1983, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.